RSS

monotherapy

Data, recently published in the journal Epilepsia, has demonstrated once-daily monotherapy, Zebinix (esclicarbazeptine acetate), is non-inferior to twice-daily controlled released carbamazepine in the treatment of newly diagnosed focal epilepsy more

News

Biopharmaceutical company, Tesaro, has revealed that the European Commission has approved its monotherapy for the maintenance treatment of women with recurrent ovarian cancer. more

News